CRISPR crew’s lab test spotlights lead program in sickle cell disease, beta-thalassemia – Endpoints News
|
CRISPR crew's lab test spotlights lead program in sickle cell disease, beta-thalassemia
Endpoints News CRISPR/Cas9 tech is still at a very early stage of development. But one of the top biotechs looking to make a breakthrough in the clinic got a chance today to explain why one of its preclinical studies helps demonstrate gene editing's promise in … European Hematology Association: Treating Sickle Cell Disease … |
